Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SHE:002864)

China flag China · Delayed Price · Currency is CNY
30.24
-0.07 (-0.23%)
Apr 30, 2026, 3:04 PM CST
13.05%
Market Cap 3.21B
Revenue (ttm) 1.11B
Net Income (ttm) 86.79M
Shares Out 105.91M
EPS (ttm) 0.83
PE Ratio 36.50
Forward PE n/a
Dividend 0.20 (0.66%)
Ex-Dividend Date n/a
Volume 1,617,100
Average Volume 2,975,004
Open 30.18
Previous Close 30.31
Day's Range 30.13 - 30.50
52-Week Range 26.56 - 42.88
Beta -0.12
RSI 36.78
Earnings Date Apr 28, 2026

About SHE:002864

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells Chinese patent medicines in China. It offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chinese medicine anti-inflammatory products. Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd was founded in 1997 and is based in Xi'an, China. [Read more]

Sector Healthcare
Founded 1997
Employees 933
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002864
Full Company Profile

Financial Performance

In 2025, SHE:002864's revenue was 1.14 billion, an increase of 17.15% compared to the previous year's 973.86 million. Earnings were 96.28 million, a decrease of -19.95%.

Financial Statements

News

There is no news available yet.